1096 related articles for article (PubMed ID: 12193750)
41. Increased number of regulatory T cells (T-regs) in the peripheral blood of patients with Her-2/neu-positive early breast cancer.
Decker T; Fischer G; Bücke W; Bücke P; Stotz F; Grüneberger A; Gropp-Meier M; Wiedemann G; Pfeiffer C; Peschel C; Götze K
J Cancer Res Clin Oncol; 2012 Nov; 138(11):1945-50. PubMed ID: 22760213
[TBL] [Abstract][Full Text] [Related]
42. [Effect of apoptosis of CD4+ CD25+ regulatory T lymphocytes on polarization of helper T lymphocytes and potential interventional influence of Xuebijing injection in septic rats].
Dai XG; Yao YM; Ai YH
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2009 Mar; 21(3):135-8. PubMed ID: 19278580
[TBL] [Abstract][Full Text] [Related]
43. Blockade of B7-H1 or B7-DC induces an anti-tumor effect in a mouse pancreatic cancer model.
Okudaira K; Hokari R; Tsuzuki Y; Okada Y; Komoto S; Watanabe C; Kurihara C; Kawaguchi A; Nagao S; Azuma M; Yagita H; Miura S
Int J Oncol; 2009 Oct; 35(4):741-9. PubMed ID: 19724910
[TBL] [Abstract][Full Text] [Related]
44. An increased abundance of tumor-infiltrating regulatory T cells is correlated with the progression and prognosis of pancreatic ductal adenocarcinoma.
Tang Y; Xu X; Guo S; Zhang C; Tang Y; Tian Y; Ni B; Lu B; Wang H
PLoS One; 2014; 9(3):e91551. PubMed ID: 24637664
[TBL] [Abstract][Full Text] [Related]
45. Tumor-Infiltrating Lymphocytes in Breast Cancer. Association with Clinical and Pathological Parameters.
Zabotina TN; Korotkova OV; Chertkova AI; Zakharova EN; Tabakov DV; Dzhgamadze NT; Savostikova MV; Artamonova EV; Khailenko VA; Kovalenko EI; Kadagidze ZG
Bull Exp Biol Med; 2018 Dec; 166(2):241-244. PubMed ID: 30488197
[TBL] [Abstract][Full Text] [Related]
46. CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses.
Kingsley CI; Karim M; Bushell AR; Wood KJ
J Immunol; 2002 Feb; 168(3):1080-6. PubMed ID: 11801641
[TBL] [Abstract][Full Text] [Related]
47. Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti-CTLA-4 therapy against melanoma.
Simpson TR; Li F; Montalvo-Ortiz W; Sepulveda MA; Bergerhoff K; Arce F; Roddie C; Henry JY; Yagita H; Wolchok JD; Peggs KS; Ravetch JV; Allison JP; Quezada SA
J Exp Med; 2013 Aug; 210(9):1695-710. PubMed ID: 23897981
[TBL] [Abstract][Full Text] [Related]
48. Interleukin-10-mediated regulatory T-cell responses to epitopes on a human red blood cell autoantigen.
Hall AM; Ward FJ; Vickers MA; Stott LM; Urbaniak SJ; Barker RN
Blood; 2002 Dec; 100(13):4529-36. PubMed ID: 12393426
[TBL] [Abstract][Full Text] [Related]
49. Phenotypic profile of dendritic and T cells in the lymph node of Balb/C mice with breast cancer submitted to dendritic cells immunotherapy.
da Cunha A; Antoniazi Michelin M; Cândido Murta EF
Immunol Lett; 2016 Sep; 177():25-37. PubMed ID: 27423825
[TBL] [Abstract][Full Text] [Related]
50. Axillary lymph node cellular immune response to HER-2/neu peptides in patients with carcinoma of the breast.
Kuerer HM; Peoples GE; Sahin AA; Murray JL; Singletary SE; Castilleja A; Hunt KK; Gershenson DM; Ioannides CG
J Interferon Cytokine Res; 2002 May; 22(5):583-92. PubMed ID: 12060497
[TBL] [Abstract][Full Text] [Related]
51. Intra-tumoral IFN-γ-producing Th22 cells correlate with TNM staging and the worst outcomes in pancreatic cancer.
Niccolai E; Taddei A; Ricci F; Rolla S; D'Elios MM; Benagiano M; Bechi P; Bencini L; Ringressi MN; Pini A; Castiglione F; Giordano D; Satolli MA; Coratti A; Cianchi F; Bani D; Prisco D; Novelli F; Amedei A
Clin Sci (Lond); 2016 Feb; 130(4):247-58. PubMed ID: 26590104
[TBL] [Abstract][Full Text] [Related]
52. PD-1(+) immune cell infiltration inversely correlates with survival of operable breast cancer patients.
Sun S; Fei X; Mao Y; Wang X; Garfield DH; Huang O; Wang J; Yuan F; Sun L; Yu Q; Jin X; Wang J; Shen K
Cancer Immunol Immunother; 2014 Apr; 63(4):395-406. PubMed ID: 24514954
[TBL] [Abstract][Full Text] [Related]
53. Generation ex vivo of TGF-beta-producing regulatory T cells from CD4+CD25- precursors.
Zheng SG; Gray JD; Ohtsuka K; Yamagiwa S; Horwitz DA
J Immunol; 2002 Oct; 169(8):4183-9. PubMed ID: 12370347
[TBL] [Abstract][Full Text] [Related]
54. Differentiation of CD8+ T cells from tumor-invaded and tumor-free lymph nodes of melanoma patients: role of common gamma-chain cytokines.
Anichini A; Scarito A; Molla A; Parmiani G; Mortarini R
J Immunol; 2003 Aug; 171(4):2134-41. PubMed ID: 12902520
[TBL] [Abstract][Full Text] [Related]
55. The role of the IL-2 pathway in costimulation blockade-resistant rejection of allografts.
Jones TR; Ha J; Williams MA; Adams AB; Durham MM; Rees PA; Cowan SR; Pearson TC; Larsen CP
J Immunol; 2002 Feb; 168(3):1123-30. PubMed ID: 11801646
[TBL] [Abstract][Full Text] [Related]
56. Preferential accumulation of regulatory T cells with highly immunosuppressive characteristics in breast tumor microenvironment.
Syed Khaja AS; Toor SM; El Salhat H; Faour I; Ul Haq N; Ali BR; Elkord E
Oncotarget; 2017 May; 8(20):33159-33171. PubMed ID: 28388539
[TBL] [Abstract][Full Text] [Related]
57. Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood.
Jonuleit H; Schmitt E; Stassen M; Tuettenberg A; Knop J; Enk AH
J Exp Med; 2001 Jun; 193(11):1285-94. PubMed ID: 11390435
[TBL] [Abstract][Full Text] [Related]
58. Activation of regulatory T cells instigates functional down-regulation of cytotoxic T lymphocytes in human breast cancer.
Li CH; Kuo WH; Chang WC; Huang SC; Chang KJ; Sheu BC
Immunol Res; 2011 Oct; 51(1):71-9. PubMed ID: 21918886
[TBL] [Abstract][Full Text] [Related]
59. Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood.
Dieckmann D; Plottner H; Berchtold S; Berger T; Schuler G
J Exp Med; 2001 Jun; 193(11):1303-10. PubMed ID: 11390437
[TBL] [Abstract][Full Text] [Related]
60. Activated but not resting regulatory T cells accumulated in tumor microenvironment and correlated with tumor progression in patients with colorectal cancer.
Lin YC; Mahalingam J; Chiang JM; Su PJ; Chu YY; Lai HY; Fang JH; Huang CT; Chiu CT; Lin CY
Int J Cancer; 2013 Mar; 132(6):1341-50. PubMed ID: 22907255
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
